Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Von Eschenbach Receiving HELP From Committee Members On GOP Hurdle

This article was originally published in The Tan Sheet

Executive Summary

Senate Health, Education, Labor & Pensions Committee members are working to avert Republican holds on the nomination of FDA Acting Commissioner Andrew von Eschenbach to the permanent post

You may also be interested in...



Misleading NDAs Beget Closer Scrutiny From FDA Staff – OND Chief Jenkins

Successful appeals of NDA rejections are rare, Office of New Drugs Director John Jenkins acknowledges, but he advises pharmaceutical firms that submitting misleading applications only increases the odds against success

Misleading NDAs Beget Closer Scrutiny From FDA Staff – OND Chief Jenkins

Successful appeals of NDA rejections are rare, Office of New Drugs Director John Jenkins acknowledges, but he advises pharmaceutical firms that submitting misleading applications only increases the odds against success

Misleading NDAs Beget Closer Scrutiny From FDA Staff – OND Chief Jenkins

Successful appeals of NDA rejections are rare, Office of New Drugs Director John Jenkins acknowledges, but he advises pharmaceutical firms that submitting misleading applications only increases the odds against success

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099792

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel